Mobile

Novel topical therapies for acne vulgaris: a randomised, controlled, double blind comparison of the antibacterial efficacy of 1% w/v formulations of tert-butylhydroquinone, zinc pyrithione and benzoyl...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-000232-12

Novel topical therapies for acne vulgaris: a randomised, controlled, double blind comparison of the antibacterial efficacy of 1% w/v formulations of tert-butylhydroquinone, zinc pyrithione and benzoyl peroxide in healthy volunteers

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the ability of : - Topical formulations of 1% TBHQ, 1%ZnP and 1% BPO - A combination of 1% TBHQ and 1% BPO applied from separate topical formulations to reduce the population density (viable count) of cutaneous propionibacteria on the upper back by >/= 90% within 14 days and to determine the length of time it takes to achieve this .

Critère d'inclusion

  • Healthy volunteer study. The product under development will be used for the treatment of acne vulgaris

Liens